Previous Article | Next Article 
Infection and Immunity, August 1999, p. 3872-3878, Vol. 67, No. 8
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Essential Role of Transcription Factor Nuclear
Factor-
B in Regulation of Interleukin-8 Gene Expression by Nitrite
Reductase from Pseudomonas aeruginosa in Respiratory
Epithelial Cells
Naoki
Mori,1,*
Kazunori
Oishi,2
Borann
Sar,2
Naofumi
Mukaida,3
Tsuyoshi
Nagatake,2
Kouji
Matsushima,4 and
Naoki
Yamamoto1
Department of Preventive Medicine and AIDS
Research1 and Department of Internal
Medicine,2 Institute of Tropical Medicine,
Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Department of Pharmacology, Cancer Research Institute, Kanazawa
University, 13-1 Takaramachi, Kanazawa
920-0934,3 and Department of Molecular
Preventive Medicine, School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033,4 Japan
Received 4 January 1999/Returned for modification 12 March
1999/Accepted 27 May 1999
 |
ABSTRACT |
Persistent infection with Pseudomonas aeruginosa
increases interleukin-8 (IL-8) levels and causes dense neutrophil
infiltrations in the airways of patients with chronic airway diseases.
Recently, we have reported that nitrite reductase from P. aeruginosa induces the production of IL-8 in respiratory cells,
including bronchial epithelial cells. To determine the molecular
mechanism(s) of nitrite reductase-induced IL-8 expression in
respiratory cells, A549 epithelial cells were transfected with plasmids
containing serial deletions of the 5'-flanking region of the IL-8 gene
and then exposed to nitrite reductase. Nitrite reductase significantly
enhanced IL-8 gene promoter-driven reporter activity. This increased
IL-8 gene expression was inhibited by mutating the nuclear factor-
B
(NF-
B) binding element. Nitrite reductase enhanced nuclear
localization of the NF-
B binding complex. Furthermore, nitrite
reductase induced the degradation of I
B
, the major cytoplasmic
inhibitor of NF-
B, and the expression of I
B
mRNA. These data
support the critical role of the activation of NF-
B in nitrite
reductase-induced IL-8 gene expression in airway epithelium.
 |
INTRODUCTION |
The importance of Pseudomonas
aeruginosa as an opportunistic pathogen in the lower respiratory
tract is well established (6, 31). Mucoid strains of
P. aeruginosa often appear as a chronic infection in the
late stages of chronic airway disease (CAD), such as cystic fibrosis
and diffuse panbronchiolitis, and worsen the prognosis of these
diseases (7, 37).
Inflammation in the airways of patients with CAD is characterized by
dense neutrophil infiltrations (9, 19). Levels of cytokines,
including interleukin-8 (IL-8), a potent neutrophil chemoattractant
factor, have been reported to be elevated in bronchoalveolar lavage
fluids from patients with such inflammatory diseases and to be
decreased after low-dose, long-term erythromycin therapy, suggesting
that these cytokines are important in airway inflammatory processes
(9, 19, 28). We previously reported that persistent P. aeruginosa infection increased the levels of IL-8 and induced dense neutrophil infiltrations in the airways of patients with CAD
(28). These observations confirmed that a perpetual cycle of
IL-8 production and neutrophil accumulation caused by persistent P. aeruginosa infection plays an important role in the
pathogenesis of CAD. IL-8 is known to be released by monocytes
(41), macrophages (4), and fibroblasts
(32), and recent data showed that airway epithelial cells
are an important source of this chemokine (8, 25, 28, 36).
Consistent with the in vivo observations, several products of P. aeruginosa stimulate bronchial epithelial cells to produce IL-8 in
vitro (5, 16). Recently, our studies indicated that a
heat-stable protein purified from the supernatants of sonicated P. aeruginosa stimulates human bronchial epithelial cells to
produce IL-8 (27). We purified the protein to homogeneity
and determined its N-terminal amino acid sequence. It completely
matched a sequence at the N-terminal part of the mature protein form of
Pseudomonas nitrite reductase (PNR) (27).
Therefore, PNR is an IL-8 inducer in human respiratory cells.
However, the mechanism(s) by which PNR activates IL-8 gene expression
in human epithelial cells has not yet been clarified. The IL-8 gene is
regulated at both the transcriptional and the posttranscriptional
levels. The former is primarily mediated by multiple cis
elements, including a CCAAT box, a steroid-responsive element, an HNF-1
element, two IRF-1 elements, an activating protein 1 (AP-1) sequence,
an AP-3 site, a C/EBP sequence, and a nuclear factor-
B
(NF-
B)-NF-IL-6 overlapping sequence (10, 18, 23, 30).
Activation of NF-
B is the most crucial step for IL-8 gene transcription in most cells, but NF-IL-6 and AP-1 binding sites are
also required for IL-8 transcriptional activation by IL-1 or tumor
necrosis factor alpha (TNF-
) (22). Synergistic
interaction between NF-
B and NF-IL-6 may play an important role in
the transcription of the IL-8 gene (11, 18). Depending on
the cell line, cooperation between NF-
B and either NF-IL-6 or AP-1
is sufficient for IL-8 gene activation (22). In resting
cells, NF-
B is present in the cytoplasm bound to its inhibitor,
I
B
(2). Subsequent to cellular activation and through
proteolytic degradation of I
B
, NF-
B is released and
translocated to the nucleus, where it transactivates several genes. As
several microbial, environmental, and inflammatory stimuli can activate
NF-
B (3, 34), the mutual regulation of NF-
B and
I
B
is critical to ensuring a transient and limited host response.
In this study, we investigated the molecular mechanisms responsible for
the induction of the IL-8 gene by PNR. We show that the NF-
B element
is essential for activation of IL-8 gene expression by PNR. On exposure
to PNR, human epithelial cells exhibit increased NF-
B activity and increased turnover of I
B
.
 |
MATERIALS AND METHODS |
Purification of PNR.
A serum-sensitive strain with a mucoid
phenotype, P. aeruginosa 5276, was isolated from a patient
with diffuse panbronchiolitis (28). This strain was grown
overnight in Mueller-Hinton broth (Difco Laboratories, Detroit, Mich.).
Bacteria in the post-log phase were harvested in sterile normal saline.
Harvested bacterial cells were sonicated 10 times with an ultrasonifier
(Cell Disruptor 185; Branson Ultrasonics Co., Danbury, Conn.) with
1-min intervals. The sonicated supernatant of P. aeruginosa
was obtained following ultracentrifugation at 18,000 × g for 60 min at 4°C and filtration through a 0.45-µm-pore-size
filter. The PNR was purified as previously described (27).
The purified PNR was stored at
80°C until use.
Cell culture and transfection.
A549 cells (Riken Cell Bank,
Tsukuba Science City, Japan), a tumor cell line with the properties of
alveolar epithelial cells (14), were cultured at 37°C in
5% CO2 in Dulbecco's modified Eagle's medium (DMEM)
containing 10% heat-inactivated fetal calf serum (GIBCO-BRL, Grand
Island, N.Y.), penicillin (50 U/ml), and streptomycin (50 µg/ml). The
cells were subcultured twice weekly.
DNA constructs.
Plasmids containing serial deletions of the
5'-flanking region of the IL-8 gene linked to luciferase expression
vectors were constructed from a firefly luciferase expression vector
(29). Site-directed mutagenesis of the IL-8 AP-1, NF-IL-6,
and NF-
B sites in the
133-luc plasmid was introduced, converting
the AP-1 site TGACTCA (
126 to
120 bp) to TatCTCA, the
NF-IL-6 site CAGTTGCAAATCGT (
94 to
81 bp) to
agcTTGCAAATCGT, and the
B site GGAATTTCCT (
80 to
71 bp) to taAcTTTCCT (sites of mutation are
indicated in lowercase). These constructs were designated as AP-1
site-mutated, NF-IL-6 site-mutated, and
B site-mutated plasmids,
respectively. Two copies of the IL-8 AP-1 binding site (TGACTCA),
three copies of the NF-IL-6 site (CAGTTGCAAATCGTG), or
three copies of the IL-8
B site (GGAATTTCCT) were
inserted upstream of the IL-8 enhancerless core promoter (
50 to +44
bp) linked to the firefly luciferase gene (
50-luc plasmid).
Transient-transfection and luciferase assay.
A549 cells were
plated at a density of 3 × 105 cells/60-mm tissue
culture plate 16 h before transfection. Transfection of plasmid DNA into A549 cells was done by the calcium phosphate coprecipitation method (21). In brief, each luciferase reporter construct (2 µg) and a cytomegalovirus promoter-Renilla luciferase
expression plasmid (0.1 µg; pRL-CMV, as an internal control) were
placed in a sterile microcentrifuge tube, and 62 µl of 2 M
CaCl2 was slowly added by drops. Then, 2× HEBS solution
(50 mM HEPES [pH 7.05], 1.5 mM Na2HPO4, 10 mM
KCl, 280 mM NaCl, and 12 mM glucose) was added. The mixture was kept
still at room temperature for 20 min. One milliliter of the above
solution was added per plate, and cells were incubated at 37°C. After
a 4-h incubation, the cells were exposed to a 15% glycerol-1× HEBS
solution for 3 min and then washed twice with serum-free DMEM. Fresh
medium was applied, and cells were incubated at 37°C. After 24 h, the transfected A549 cells were incubated in serum-free DMEM in the
absence or the presence of PNR (5 µg/ml) and incubated at 37°C. To
measure reporter gene expression, cells were harvested 6 h later
and resuspended in 250 µl of lysis buffer. The cells were then lysed
by freeze-thaw and centrifuged, and 20 µl of supernatant was
evaluated for luciferase activity with a Lumat model LB9505C
luminometer (Berthold, Bad Wildbad, Germany). Levels of luciferase
expression were normalized to Renilla luciferase activity.
Each experiment was performed three times.
Nuclear extract preparation.
Nuclear extracts from A549
cells were prepared as previously described (1). After the
treatment indicated, cells were scraped and washed in
phosphate-buffered saline and then resuspended in 200 µl of cold
buffer A (10 mM HEPES [pH 7.9], 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA,
1 mM dithiothreitol [DTT], and 2 mM aminoethyl benzenesulfonyl
fluoride). After the cells were allowed to swell at 4°C for 10 min,
they were lysed in the presence of Nonidet P-40 (final concentration,
0.8%). The homogenate was centrifuged for 5 min at 400 × g, and the nuclear pellet was resuspended in 75 µl of cold
buffer C (20 mM HEPES [pH 7.9], 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 2 mM aminoethyl benzenesulfonyl fluoride, 33 µg of aprotinin
per ml, 10 µg of leupeptin per ml, 10 µg of pepstatin per ml, and
10 µg of E-64 per ml). This suspension was agitated at 4°C for 30 min, followed by microcentrifugation for 15 min at 4°C. The resulting
supernatant was stored in small aliquots at
80°C. Protein
concentrations were determined by the Bradford method (Bio-Rad protein
assay) with bovine serum albumin as a standard.
Electrophoretic mobility shift assay (EMSA).
EMSAs were
performed as previously described (20). Binding sites for
double-stranded oligonucleotides,
B (5'-CGTGGAATTTCCTCTG-3',
83 to
68 bp) and AP-1 (5'-GTGATGACTCAGGTT-3',
130 to
116 bp), from the IL-8 promoter were end labeled with
[
-32P]dCTP and [
-32P]dATP with the
large-fragment DNA polymerase (Klenow) (GIBCO-BRL) and were used as
probes. The binding reactions were performed at room temperature, and
the reaction mixtures contained 20 µl of binding buffer (10 mM
Tris-HCl [pH 7.5], 50 mM NaCl, 1 mM EDTA, 5% glycerol, and 1 mM
DTT), 5 µg of nuclear proteins, and 1 µg of poly(dI-dC) (Pharmacia,
Piscataway, N.J.). After 15 min at room temperature, 50,000 cpm of
32P-labeled DNA probe was added to the reaction mixture for
15 min at room temperature. The DNA-protein complexes were separated on
native 4% polyacrylamide gels (prerun at 150 V for 30 min) in 0.25×
TBE buffer (22.3 mM Tris-HCl [pH 7.5], 22.2 mM boric acid, and 0.5 mM
EDTA) at 150 V for 2 h at 4°C. After electrophoresis was
performed, the gels were dried and exposed for autoradiography. In
competition studies, a 25-fold excess of unlabeled wild-type oligonucleotides, oligonucleotides corresponding to the
B element from IL-2 receptor
(5'-CGGCAGGGGAATCTCCCTCTC-3'),
oligonucleotides containing the consensus sequence for the AP-1
DNA binding site (5'-CGCTTGATGAGTCAGCCGGAA-3'), or
oligonucleotides containing mutant NF-
B
(5'-CGTtaAcTTTCCTCTG-3') or AP-1
(5'-GTGATatCTCAGGTT-3') binding sites (sites of mutation are
indicated in lowercase) was included in the reaction mixture along with
the radiolabeled probe. For supershift experiments, affinity-purified
rabbit antibodies (2 µg/reaction) to p50, p65, c-Rel, p52, c-Fos,
FosB, Fra-1, Fra-2, c-Jun, JunB, or JunD (Santa Cruz Biotechnology,
Inc., Santa Cruz, Calif.) were incubated in the standard reaction
mixture and incubated at room temperature for 45 min before the labeled
oligonucleotides were added.
Western blot analysis.
The antibody used in these
experiments was a rabbit polyclonal antibody to I
B
, C-21 (Santa
Cruz Biotechnology, Inc.). Cells were retrieved by scraping, washed,
and lysed by incubation in radioimmunoprecipitation assay buffer (0.5%
sodium deoxycholate, 1% Nonidet P-40, 0.1% sodium dodecyl sulfate, 66 µg of aprotinin per ml, 100 µg of phenylmethylsulfonyl fluoride per
ml, and 1 mM sodium orthovanadate) for 30 min at 4°C. Equal amounts
(50 µg) of protein from cell lysates were electrophoresed on sodium dodecyl sulfate-10% polyacrylamide gel electrophoresis gels and transferred to polyvinylidene difluoride membranes. The membranes were
washed with Tris-buffered saline-Tween (0.05%) with 3% nonfat dried
milk overnight at 4°C and then blotted for 45 min with the antibody.
The membranes were washed with Tris-buffered saline-Tween and
incubated with a 1:5,000 dilution of horseradish peroxidase-conjugated anti-rabbit immunoglobulin (Amersham, Arlington Heights, Ill.). Thereafter, membranes were developed with enhanced chemiluminescence reagents (Amersham) and exposed to film.
RNA extraction and reverse transcriptase PCR.
Total RNA was
isolated with Trizol reagent (GIBCO-BRL) according to the
manufacturer's recommendations and converted to single-strand cDNA
with an oligo(dT) primer and reverse transcriptase under reaction
conditions as described previously (27). PCR was performed on the cDNA after the addition of Taq DNA polymerase,
deoxynucleoside triphosphate, and each primer with a DNA thermal cycler
(Perkin-Elmer, Branchburg, N.J.) as previously described
(27). An aliquot of each reaction mixture was then analyzed
by electrophoresis on a 1% agarose gel, and the amplified DNA band was
visualized by ethidium bromide staining. The amplification products of
human IL-8 and human glyceraldehyde triphosphate dehydrogenase (GAPDH) were 983 and 750 bp, respectively.
Northern blot analysis.
Equal amounts of RNA (20 µg per
lane) were loaded and run on a 1% agarose-formaldehyde gel. RNA was
then transferred to a nylon membrane and hybridized to a cDNA probe
encoding human I
B
, a kind gift of Dean W. Ballard (Vanderbilt
University School of Medicine, Nashville, Tenn.). A cDNA probe for
human GAPDH was used to confirm equal loading of RNA in all the wells.
All probes were labeled with [
-32P]dCTP with a random
primer labeling kit (Amersham).
Statistical analysis.
Statistical analysis of results was
performed with Student's t test.
 |
RESULTS |
Effect of PNR on IL-8 mRNA.
Initial studies were performed to
examine IL-8 transcription following PNR exposure. Reverse
transcriptase PCR analyses demonstrated that A549 cells did not express
IL-8 mRNA transcripts constitutively but expressed them markedly after
exposure to PNR (Fig. 1). Control GAPDH
mRNA transcripts were observed in similar amounts in both unstimulated
cells and cells exposed to PNR.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
The effect of PNR on IL-8 gene expression in A549
bronchial epithelial cells. The IL-8 mRNA expression induced by PNR (5 µg/ml) for 3 h is shown. M, molecular mass markers.
|
|
A sequence spanning positions
98 to
50 of the IL-8 gene
promoter is sufficient to mediate activation by PNR.
To delineate
the mechanism by which PNR induces IL-8 gene transcription,
PNR-responsive promoter elements in the IL-8 promoter were identified
in this study. This was done by transfecting A549 cells with plasmid
constructs containing the luciferase reporter gene driven by the IL-8
promoter (Fig. 2A). Twenty-four hours posttransfection, cells were stimulated with PNR. The full-length promoter was reproducibly activated by PNR. These results indicate that
PNR induces IL-8 expression in A549 cells at the level of transcription. Deletion of sequences upstream of position
98 decreased the constitutive promoter activity but had little effect on
PNR inducibility (Fig. 2B). In contrast, deletion of sequences upstream
of
50 abolished inducibility by PNR. This maps the region from
98
to
50 bp as a PNR-responsive region which is likely to contain
individual PNR-responsive regulatory elements.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
Sequences within 98 to 50 bp of the IL-8 promoter
are necessary for activation by PNR. (A) Schematic representation of
the 5'-flanking region of the IL-8 gene, demonstrating locations of
several known binding sites for transcription factors. (B) Effect of
PNR on IL-8 gene expression in A549 epithelium. A549 cells were
transfected with plasmids containing serial deletions in the
5'-flanking region of the IL-8 gene. After 24 h, cells were
incubated for 6 h with either medium alone (control) or PNR (5 µg/ml). Relative luciferase activity was calculated from the
luciferase activity of each reporter plasmid relative to the value of
50-luc, incubated with medium alone and assigned a value of 1. Data
are also expressed as fold increases in luciferase activity in
PNR-exposed cells over that in control cells. These results represent
the averages of three independent experiments. Error bars indicate
standard errors. The mean fold increase relative to the untreated
medium control was significantly lower in 50-luc than in the other
reporter plasmids (P < 0.01).
|
|
Previous studies have shown that the AP-1 or the NF-IL-6 site acts
cooperatively with NF-

B to induce IL-8 gene transcription
(
11,
18,
22). To identify the
cis-acting elements in the

133 to

50 bp region of the IL-8 promoter which served as a
PNR-responsive
regulatory element, site-directed mutant constructs were
prepared
and tested (Fig.
3A). The
results shown in Fig.
3B indicate that
mutation in the NF-

B site
(NF-

B mut-luc) resulted in a significant
reduction of IL-8
inducibility by PNR. Mutation of the AP-1 site
(AP-1 mut-luc) decreased
basal activity but had no effect on PNR-induced
luciferase activity.
However, mutation of the NF-IL-6 site (NF-IL-6
mut-luc) resulted in no
decrease in either the basal activity
or the activity inducible by PNR.
These results indicate that
activation of the IL-8 promoter in A549
epithelial cells in response
to PNR stimulation requires an intact
binding site for the NF-

B
element.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
The relative importance of the AP-1, NF-IL-6, and
NF- B binding sites in the IL-8 promoter. (A) The constructs used are
diagrammed. The AP-1 site, NF-IL-6 site, or B site in the IL-8
promoter ( 133 to +44 bp), linked to the luciferase gene, was mutated.
(B) The wild-type and mutated plasmids were transfected into A549
cells. The transfected cells were incubated without PNR (open bars) or
with PNR (5 µg/ml) (solid bars). After a 6-h incubation, the
luciferase activity was determined. Relative luciferase activity was
calculated from the luciferase activity of each reporter plasmid
relative to the value of 50-luc, incubated with medium alone and
assigned a value of 1. Mean fold increase relative to the untreated
medium control was significantly lower in NF- B mut-luc than in
133-luc (P < 0.01).
|
|
The NF-
B site of the IL-8 gene is sufficient to mediate
PNR-induced gene activation.
The IL-8 gene fragment spanning
positions
133 to
50 bp contains three prominent DNA-protein
interaction sites for the transcription factors AP-1, NF-IL-6, and
NF-
B. To further determine which sites are sufficient for activation
by PNR, several constructs were used (Fig.
4). Each construct contained three
tandemly repeated copies of one of the following elements: the NF-
B
or NF-IL-6 site from the IL-8 gene or two copies of the AP-1 binding
site from the IL-8 gene. Each was linked to the minimal IL-8 promoter spanning
50 to +44 bp and to the luciferase reporter gene.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 4.
PNR-induced IL-8 gene expression is specific for the
B region of the IL-8 gene. PNR induces luciferase expression in A549
cells transfected with ×3 IL-8 B site-luc. Relative luciferase
activity was calculated from the luciferase activity of each reporter
plasmid relative to the value of 50-luc, incubated with medium alone
and assigned a value of 1. Mean fold increase relative to the untreated
medium control was significantly higher in ×3 IL-8 B site-luc than
in 50-luc (P < 0.01).
|
|
The construct ×3 IL-8

B site-luc, which contains three tandem
repeats of the NF-

B site from the IL-8 gene, generated a 14.6-fold
stimulation by PNR. In contrast, constructs ×2 AP-1 site-luc and
×3
NF-IL-6 site-luc did not exhibit PNR inducibility in A549 cells
(Fig.
4). These results demonstrate that the NF-

B site of the
IL-8 gene is
important for activation of PNR-induced gene expression.
In contrast,
the AP-1 and NF-IL-6 sites, essential for IL-8 induction
by various
stimuli in other cell types, are not involved in this
form of PNR
responsiveness.
Stimulation with PNR induces a single predominant
B binding
complex, while AP-1 is constitutively expressed in A549 cells.
To
investigate the trans-acting factors that are involved in
the activation of IL-8 by PNR, we performed EMSA with a probe spanning
positions
83 to
68 bp of the IL-8 promoter, which includes the
NF-
B binding site at
80 to
71 bp (Fig.
5A). PNR treatment for 3 h induced a
single predominant
B binding complex (Fig. 5A, lanes 1 and 2). This
binding was specifically competed by an excess of wild-type unlabeled
NF-
B from the IL-8 gene or the IL-2 receptor
gene (Fig. 5A,
lanes 3 and 4) but not by an oligonucleotide containing point mutations
which abolished NF-
B binding (Fig. 5A, lane 5). To further
characterize the
B complex, supershift experiments using specific
antisera were performed. An antibody against NF-
B p50 or p65
specifically shifted and diminished the formation of complex (Fig. 5B,
lanes 2 and 3), while an antibody against c-Rel or p52 had no effect
(Fig. 5B, lanes 4 and 5). These data suggest that this DNA-protein
complex represents a p50-p65 heterodimer product. In contrast, AP-1
binding was constitutively present in nuclei from unstimulated
cultures, appearing as a single band on EMSA (Fig.
6A, lane 1). Nuclear extracts from
PNR-treated A549 cells incubated with the AP-1 probe showed no increase
in binding over unstimulated extracts (Fig. 6A, lane 2). The complex was specifically competed by the IL-8 AP-1 or consensus AP-1 probe but
not by the mutant AP-1 fragment (Fig. 6A, lanes 3 to 5). To determine
if the complex contains AP-1, antibodies were used in a supershift
assay. Anti-Fra-2 and anti-JunD antibodies reduced the complex and
resulted in supershifted bands (Fig. 6B, lanes 5 and 8). Taken
together, the cold competition and supershift assays indicate that
PNR-induced proteins bind the NF-
B site but not the AP-1 site, which
is in agreement with the functional data shown in Fig. 2 to 4.

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 5.
Induction of specific NF- B complex formation by
exposure of A549 cells to PNR. (A) Characterization of nuclear proteins
bound to the NF- B binding site of the IL-8 gene. Nuclear proteins
were extracted from A549 cells cultured for 3 h without (lane 1)
or with (lanes 2 to 5) PNR. EMSA was performed on nuclear extracts
preincubated with no reagents (lanes 1 and 2) or the indicated
competitors (lanes 3 to 5), and the NF- B binding site of the IL-8
gene was used as a labeled probe. (B) Further characterization of
nuclear proteins bound to the B binding site of the IL-8 gene.
Nuclear proteins were extracted from A549 cells that were cultured with
PNR for 3 h. EMSA was performed on nuclear proteins preincubated
with no reagents (lane 1) or the indicated antisera (lanes 2 to 5), and
the B binding site of the IL-8 gene was used as a labeled probe. Ab,
antibody. Arrows indicate the specific complex.
|
|

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 6.
The AP-1 binding complex is constitutively expressed in
A549 cells. (A) Nuclear extracts containing equal protein
concentrations from A549 cells unstimulated or stimulated with PNR were
analyzed for AP-1 binding activity by EMSA. The IL-8 AP-1 probe was
incubated with nuclear extracts from unstimulated cells (lane 1) or
PNR-stimulated A549 cells alone (lanes 2 to 5), without (lane 2) or
with (lanes 3 to 5) a 25-fold excess of the indicated competitors. (B)
Anti-Fra-2 and anti-JunD sera recognize AP-1 binding complex in nuclear
extracts from A549 cells. Nuclear extracts from A549 cells that were
unstimulated were analyzed for AP-1 binding by EMSA. The AP-1 probe was
incubated with nuclear extracts from A549 cells. The nuclear extracts
were preincubated for 45 min with the indicated antibodies (Ab) (lanes
2 to 8). Arrows indicate the specific complex.
|
|
Activation of I
B
by PNR.
Since signal-induced
proteolytic degradation of I
B
precedes the appearance of NF-
B
DNA binding activity, we examined the conditions for activation of
I
B
in A549 cells that were stimulated by PNR. Kinetic analysis of
PNR-induced degradation of I
B
in A549 cells revealed gradual
replacement of I
B
levels, complete restoration of I
B
levels
to those in unstimulated A549 cells being achieved after 3 h of
culture (Fig. 7A). Immunoblots of whole-cell extracts of A549 cells that were cultured with PNR or medium
for 1 h were prepared (Fig. 7B). Cycloheximide (50 µg/ml) was
added to some dishes along with PNR. In PNR-stimulated A549 cells, loss
of I
B
reactivity was observed at 1 h. Cycloheximide inhibited the partial recovery of I
B
levels in stimulated A549 cells, suggesting that accumulation of I
B
in A549 cells after activation depends on new protein synthesis.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 7.
Induction of I B in PNR-stimulated A549 cells. (A)
Kinetic analysis of I B activity in A549 cells cultured without
( ) or with (+) (5 µg/ml) PNR for the indicated time. Degradation of
I B is seen as early as 5 min after stimulation of A549 cells with
PNR and is completed by 30 min. Restoration of I B levels in
PNR-stimulated A549 cells to that in unstimulated A549 cells is seen
after 3 h of culture. (B) A549 cells were cultured with PNR (5 µg/ml) for 1 h in the presence or the absence of cycloheximide
(CHX; 50 µg/ml).
|
|
Induction of I
B
mRNA expression in A549 cells by PNR.
It
is possible that PNR suppressed the transcription of the I
B
gene.
To examine this possibility, we carried out Northern blot analysis of
I
B
mRNA expression in A549 cells stimulated with PNR. A549 cells
were cultured with PNR or medium, and total RNA was extracted at 1 h of culture. Induction of I
B
mRNA by PNR was observed (Fig.
8). It was reported previously that
transcription of the I
B
gene is regulated by the NF-
B binding
site in the promoter and is activated by NF-
B p65 or c-Rel
(12). These results clearly indicate that the decrease of
I
B
protein induced by PNR did not result from suppression of
transcription but from modulation of posttranscriptional events,
probably at the protein level. Cumulatively, these results indicate
that PNR activates A549 cells, as reflected by a loss of I
B
protein and up-regulation of its mRNA.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 8.
Induction of I B mRNA in A549 cells by PNR. A549
cells were cultured with PNR (5 µg/ml, lane 3) or medium alone (lane
2) for 1 h. Total RNA was assessed for I B expression. Equal
loading was assessed by hybridization of a stripped blot with a probe
for GAPDH.
|
|
 |
DISCUSSION |
P. aeruginosa affects neutrophil recruitment into the
airways by direct and indirect mechanisms. Among the chemotactic
factors for neutrophils produced by the airways, IL-8 is one of the
most potent. Because epithelial cells are sources of IL-8 in the
airways, we and others hypothesized that P. aeruginosa may
affect neutrophil migration by stimulating the production of IL-8 in
airway epithelial cells. This hypothesis provides an important model to
elucidate the mechanism by which P. aeruginosa infection
increases IL-8 levels and causes dense neutrophil infiltration in the
airways of patients with CAD. Previous studies have shown that a
nonprotein factor of less than 1 kDa in culture supernatant of P. aeruginosa stimulates IL-8 expression and production by bronchial
epithelial cells (16). Pilin-mediated adherence of P. aeruginosa as well as Pseudomonas autoinducer was
reported to be a potent stimulus for IL-8 production by bronchial
epithelial cells (5). Through the analysis of an inducer
among Pseudomonas products for IL-8 production in bronchial
epithelial cells, we have recently reported the nitrite reductase from
P. aeruginosa to be a potent IL-8 inducer in respiratory
cells (27). The PNR, with a molecular mass of 60,204 Da, is
recognized as a periplasmic component active in energy generation
(35). This enzyme oxidizes reduced Pseudomonas cytochrome c551 under aerobic conditions and
also reduces nitrite to nitric oxide by using reduced
Pseudomonas cytochrome c551 under anaerobic conditions (38, 39). It seems that the purified PNR did not stimulate epithelial cells to produce IL-8 by released nitric oxide through its enzymatic reaction, because in vitro cultures
were under aerobic conditions without electron donors such as
Pseudomonas cytochrome c551
(38). Our previous studies with reduced
Pseudomonas cytochrome c551 under
aerobic conditions showed loss of potent cytochrome oxidase activity in
the purified PNR (27). Indeed, the purified PNR did not
stimulate nitric oxide production under the culture conditions (data
not shown). Therefore, the enzymatic activity of PNR is not essential
for the IL-8-inducing activity of PNR, and a direct stimulation of bronchial epithelial cells by the PNR is a possible mechanism for IL-8
gene induction (27).
We have recently reported that PNR could be released from P. aeruginosa after exposure to antimicrobial agents or complement and that released PNR is active in inducing IL-8 production by bronchial epithelial cells (33). Moreover, we found
increased levels of immunoglobulin G and immunoglobulin A antibodies
against PNR in sera from patients with CAD and P. aeruginosa
infections. However, hyperimmune sera from these patients did not
neutralize PNR-mediated IL-8 induction in bronchial epithelial cells
(26).
This study was done to define the sites in the IL-8 promoter that are
required for PNR induction of IL-8 gene expression in airway
epithelium. Optimal PNR-induced IL-8 gene activation required an
NF-
B binding site in the 5'-flanking region of the gene. In addition, PNR incubation directly results in activation of the transcription factor that binds to this site, NF-
B.
We initially demonstrated, by use of luciferase constructs with serial
deletions in the IL-8 promoter, that the region between
1481 and
98
bp in the 5'-flanking region of the IL-8 gene is not essential for
PNR-induced IL-8 gene expression. Further deletions up to
50 bp
completely abolished the response of the promoter to PNR. This suggests
that the region between
98 and
50 bp contains elements that are
essential for PNR induction of IL-8 gene activation. Within this
segment of the 5'-flanking region of the IL-8 gene, there are several
potential binding sites for transcription factors, including NF-
B
and NF-IL-6 (Fig. 2A).
Several prior studies, using various stimuli and cell lines,
demonstrated that NF-
B and NF-IL-6 play a vital role in the regulation of IL-8 gene expression. The studies also suggested that
each factor may possess a variable degree of importance, depending on
the cell line and the stimulus used (22), and that induction
of the IL-8 gene by TNF-
, IL-1, phorbol myristate acetate, and
hepatitis B virus protein X requires the cooperative effect of NF-
B
and NF-IL-6 (15, 23). On the other hand, IL-8 gene activation by TNF-
, gamma interferon, cytomegalovirus, and
paclitaxel appears to be mediated by the AP-1 site in conjunction with
the NF-
B site in a human gastric cancer cell line (40), a
monocytic cell line (24), and a human ovarian carcinoma cell
line (13). In contrast to previous reports, we now report
that PNR induction of IL-8 is independent of intact NF-IL-6 and AP-1
sites. These results suggest that different sets of nuclear
transcription factors may be responsible for the regulation of IL-8
gene transcription in a cell type- and stimulus-specific manner.
Interestingly, AP-1 was the preferred transcription factor (over
NF-IL-6) for cooperative interaction with NF-
B for IL-8 gene
expression in respiratory syncytial virus-infected A549 cells
(17). However, our present results demonstrate that the
activation of NF-
B, but not that of NF-IL-6 and AP-1, was
indispensable for PNR-induced IL-8 gene transcription, suggesting that
the molecular mechanism involved in IL-8 gene transcription differed,
even within the same cell, depending on the employed stimuli.
To complement these observations, we also determined if PNR could
induce the degradation of I
B
in A549 epithelial cells. Similar to
other transient stimuli, PNR induced the degradation of I
B
in
A549 cells. Degradation of I
B
in PNR-induced A549 cells was
associated with translocation of NF-
B and increased steady-state
transcription of I
B
mRNA. Further, the levels of I
B
protein
in PNR-induced A549 cells were restored to a level similar to that of
unstimulated A549 cells after 3 h of incubation. Restoration of
I
B
in PNR-stimulated A549 cells was sensitive to the effect of
cycloheximide, indicating a dependency on new protein synthesis.
Infections with P. aeruginosa trigger dense neutrophil
infiltrations in the airways of patients with CAD (28).
PNR-induced NF-
B activation and the subsequent up-regulation of IL-8
could contribute to inflammatory cell recruitment. Because of its
pivotal role in inflammation, NF-
B could be an obvious target for
new types of anti-inflammatory treatments for CAD. Blocking the
activation of NF-
B may prevent the early events in the inflammatory
cascade, decreasing P. aeruginosa-induced inflammation.
In summary, we have shown that PNR regulates IL-8 gene expression at
the transcriptional level, acting through the 5'-flanking region of the
IL-8 gene. The transcriptional factor NF-
B is necessary for
PNR-induced IL-8 up-regulation, indicating one molecular mechanism of
P. aeruginosa-induced airway inflammation.
 |
ACKNOWLEDGMENTS |
We thank Dean W. Ballard for providing the cDNA probe encoding
human I
B
. We gratefully acknowledge Mika Yamamoto and Masako Sasaki for excellent technical assistance and Bent W. Nielsen for his
helpful comments during the preparation of the manuscript.
This work was supported by a Grant-in-Aid for Encouragement of Young
Scientists from the Ministry of Education, Science, Sports and Culture
of Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Preventive Medicine and AIDS Research, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan. Phone:
81-95-849-7846. Fax: 81-95-849-7805. E-mail:
n-mori{at}net.nagasaki-u.ac.jp.
Editor:
J. R. McGhee
 |
REFERENCES |
| 1.
|
Antalis, T. M., and D. Godbolt.
1991.
Isolation nuclei from hematopoietic cell types.
Nucleic Acids Res.
19:4301[Free Full Text].
|
| 2.
|
Baeuerle, P. A., and D. Baltimore.
1988.
I B: a specific inhibitor of the NF- B transcriptional factor.
Science
242:540-546[Abstract/Free Full Text].
|
| 3.
|
Baeuerle, P. A., and T. Henkel.
1994.
Function and activation of NF- B in the immune system.
Annu. Rev. Immunol.
12:141-179[Medline].
|
| 4.
|
Carre, P. C.,
R. L. Mortenson,
T. E. King, Jr.,
P. W. Noble,
C. L. Sable, and D. W. H. Riches.
1991.
Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis: a potential mechanism for the recruitment and activation of neutrophils in lung fibrosis.
J. Clin. Investig.
88:1802-1810.
|
| 5.
|
DiMango, E.,
H. J. Zar,
R. Bryan, and A. Prince.
1995.
Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8.
J. Clin. Investig.
96:2204-2210.
|
| 6.
|
Fick, R. B., Jr.
1989.
Pathogenesis of the Pseudomonas lung infection in cystic fibrosis. Clinical implication of basic research.
Chest
96:158-164[Free Full Text].
|
| 7.
|
Hoiby, N.
1977.
Pseudomonas aeruginosa infection in cystic fibrosis: diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.
Acta Pathol. Microbiol. Scand.
262:1-96.
|
| 8.
|
Inoue, H.,
P. P. Massion,
I. F. Ueki,
K. M. Grattan,
M. Hara,
A. F. Dohrman,
B. Chan,
J. A. Lausier,
J. A. Golden, and J. A. Nadel.
1994.
Pseudomonas stimulates interleukin-8 mRNA expression selectively in airway epithelium, in gland ducts, and in recruited neutrophils.
Am. J. Respir. Cell Mol. Biol.
11:651-653[Abstract].
|
| 9.
|
Kadota, J.,
O. Sakito,
S. Khono,
H. Sawa,
H. Mukae,
H. Oda,
K. Kawakami,
K. Fukushima,
K. Hiratani, and K. Hara.
1993.
A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis.
Am. Rev. Respir. Dis.
147:153-159[Medline].
|
| 10.
|
Kunsch, C., and C. A. Rosen.
1993.
NF- B subunit-specific regulation of the interleukin-8 promoter.
Mol. Cell. Biol.
13:6137-6146[Abstract/Free Full Text].
|
| 11.
|
Kunsch, C.,
R. K. Lang,
C. A. Rosen, and M. F. Shannon.
1994.
Synergistic transcriptional activation of the IL-8 gene by NF- B p65 (RelA) and NF-IL-6.
J. Immunol.
153:153-164[Abstract].
|
| 12.
|
Le Bail, O.,
R. Schmidt-Ullrich, and A. Israel.
1993.
Promoter analysis of the gene encoding the I B- /MAD3 inhibitor of NF- B: positive regulation by members of the rel/NF- B family.
EMBO J.
12:5043-5049[Medline].
|
| 13.
|
Lee, L.-F.,
J. S. Haskill,
N. Mukaida,
K. Matsushima, and J. P.-Y. Ting.
1997.
Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter.
Mol. Cell. Biol.
17:5097-5105[Abstract].
|
| 14.
|
Lieber, M.,
B. Smith,
A. Szakal,
W. Nelson-Rees, and G. Todaro.
1976.
A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells.
Int. J. Cancer
17:62-70[Medline].
|
| 15.
|
Mahe, Y.,
N. Mukaida,
K. Kuno,
M. Akiyama,
N. Ikeda,
K. Matsushima, and S. Murakami.
1991.
Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor B and CCAAT/enhancer-binding protein-like cis-elements.
J. Biol. Chem.
266:13759-13763[Abstract/Free Full Text].
|
| 16.
|
Massion, P. P.,
H. Inoue,
J. Richman-Eisenstat,
D. Grunberger,
P. G. Jorens,
B. Housset,
J.-F. Pittet,
J. P. Wiener-Kronish, and J. A. Nadel.
1994.
Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro.
J. Clin. Investig.
93:26-32.
|
| 17.
|
Mastronarde, J. G.,
M. M. Monick,
N. Mukaida,
K. Matsushima, and G. W. Hunninghake.
1998.
Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor- B in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium.
J. Infect. Dis.
177:1275-1281[Medline].
|
| 18.
|
Matsusaka, T.,
K. Fujikawa,
Y. Nishio,
N. Mukaida,
K. Matsushima,
T. Kishimoto, and S. Akira.
1993.
Transcription factors NF-IL6 and NF- B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.
Proc. Natl. Acad. Sci. USA
90:10193-10197[Abstract/Free Full Text].
|
| 19.
|
McElvaney, N. G.,
H. Nakamura,
P. Birrer,
C. A. Hebert,
W. L. Wong,
M. Alphonso,
J. B. Baker,
M. A. Catalano, and R. G. Crystal.
1992.
Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
J. Clin. Investig.
90:1296-1301.
|
| 20.
|
Mori, N., and D. Prager.
1995.
Transactivation of the interleukin-1 promoter by human T-cell leukemia virus type I and type II Tax proteins.
Blood
87:3410-3417[Abstract/Free Full Text].
|
| 21.
|
Mori, N.,
S. Murakami,
S. Oda,
D. Prager, and S. Eto.
1995.
Production of interleukin 8 in adult T-cell leukemia cells: possible transactivation of the interleukin 8 gene by human T-cell leukemia virus type I tax.
Cancer Res.
55:3592-3597[Abstract/Free Full Text].
|
| 22.
|
Mukaida, N.,
S. Okamoto,
Y. Ishikawa, and K. Matsushima.
1994.
Molecular mechanism of interleukin-8 gene expression.
J. Leukoc. Biol.
56:554-558[Abstract].
|
| 23.
|
Mukaida, N.,
Y. Mahe, and K. Matsushima.
1990.
Cooperative interaction of nuclear factor- B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines.
J. Biol. Chem.
265:21128-21132[Abstract/Free Full Text].
|
| 24.
|
Murayama, T.,
Y. Ohara,
M. Obuchi,
K. S. A. Khabar,
H. Higashi,
N. Mukaida, and K. Matsushima.
1997.
Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1 and NF- B-binding sites of the interleukin-8 gene.
J. Virol.
71:5692-5695[Abstract].
|
| 25.
|
Nakamura, H.,
K. Yoshimura,
H. A. Jaffe, and R. G. Crystal.
1991.
Interleukin-8 gene expression in human bronchial epithelial cells.
J. Biol. Chem.
266:19611-19617[Abstract/Free Full Text].
|
| 26.
| Oishi, K. Unpublished data.
|
| 27.
|
Oishi, K.,
B. Sar,
A. Wada,
Y. Hidaka,
S. Matsumoto,
H. Amano,
F. Sonoda,
S. Kobayashi,
T. Hirayama,
T. Nagatake, and K. Matsushima.
1997.
Nitrite reductase from Pseudomonas aeruginosa induces inflammatory cytokines in cultured respiratory cells.
Infect. Immun.
65:2648-2655[Abstract].
|
| 28.
|
Oishi, K.,
F. Sonoda,
S. Kobayashi,
A. Iwagaki,
T. Nagatake,
K. Matsushima, and K. Matsumoto.
1994.
Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases.
Infect. Immun.
62:4145-4152[Abstract/Free Full Text].
|
| 29.
|
Okamoto, S.,
N. Mukaida,
K. Yasumoto,
N. Rice,
Y. Ishikawa,
H. Horiguchi,
S. Murakami, and K. Matsushima.
1994.
The interleukin-8 AP-1 and B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization.
J. Biol. Chem.
269:8582-8589[Abstract/Free Full Text].
|
| 30.
|
Oliveira, I. C.,
N. Mukaida,
K. Matsushima, and J. Vilcek.
1994.
Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF- B site.
Mol. Cell. Biol.
14:5300-5308[Abstract/Free Full Text].
|
| 31.
|
Pennington, J. E.,
H. Y. Reynolds, and P. P. Carbone.
1973.
Pseudomonas pneumonia: a retrospective study of 36 cases.
Am. J. Med.
55:155-160[Medline].
|
| 32.
|
Rolfe, M. W.,
S. L. Kunkel,
T. J. Standiford,
S. W. Chensue,
R. M. Allen,
H. L. Evanoff,
S. H. Phan, and R. M. Strieter.
1991.
Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking.
Am. J. Respir. Cell Mol. Biol.
5:493-501.
|
| 33.
|
Sar, B.,
K. Oishi,
A. Wada,
T. Hirayama,
K. Matsushima, and T. Nagatake.
1999.
Nitrite reductase from Pseudomonas aeruginosa released by antimicrobial agents and complement induces interleukin-8 production in bronchial epithelial cells.
Antimicrob. Agents Chemother.
43:794-801[Abstract/Free Full Text].
|
| 34.
|
Siebenlist, U.,
G. Franzoso, and K. Brown.
1994.
Structure, regulation and function of NF- B.
Annu. Rev. Cell Biol.
10:405-455.
|
| 35.
|
Silvestrini, M. C.,
C. L. Galeotti,
M. Gervais,
E. Schinina,
D. Barra,
F. Bossa, and M. Brunori.
1989.
Nitrite reductase from Pseudomonas aeruginosa: sequence of the gene and the protein.
FEBS Lett.
254:33-38[Medline].
|
| 36.
|
Takizawa, H.,
T. Ohtoshi,
T. Kikutani,
H. Okazaki,
N. Akiyama,
M. Sato,
S. Shoji, and K. Ito.
1995.
Histamine activates bronchial epithelial cells to release inflammatory cytokines in vitro.
Int. Arch. Allergy Immunol.
108:260-267[Medline].
|
| 37.
|
Tanimoto, H.
1991.
A review of the recent progress in treatment of patients with diffuse panbronchiolitis associated with Pseudomonas aeruginosa infection in Japan.
Antibiot. Chemother. (Basel)
44:94-98.
|
| 38.
|
Yamanaka, T., and K. Okunuki.
1963.
Crystalline Pseudomonas cytochrome oxidase. I. Enzymatic properties with special reference to the biological specificity.
Biochim. Biophys. Acta
67:379-393[Medline].
|
| 39.
|
Yamanaka, T.,
S. Kijimoto, and K. Okunuki.
1963.
Biological significance of Pseudomonas cytochrome oxidase in Pseudomonas aeruginosa.
J. Biochem.
53:416-421[Free Full Text].
|
| 40.
|
Yasumoto, K.,
S. Okamoto,
N. Mukaida,
S. Murakami,
M. Mai, and K. Matsushima.
1992.
Tumor necrosis factor and interferon synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF- B-like binding sites of the interleukin 8 gene.
J. Biol. Chem.
267:22506-22511[Abstract/Free Full Text].
|
| 41.
|
Yoshimura, T.,
K. Matsushima,
J. J. Oppenheim, and E. J. Leonard.
1987.
Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).
J. Immunol.
139:788-793[Abstract].
|
Infection and Immunity, August 1999, p. 3872-3878, Vol. 67, No. 8
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Venza, I., Cucinotta, M., Visalli, M., De Grazia, G., Oliva, S., Teti, D.
(2009). Pseudomonas aeruginosa Induces Interleukin-8 (IL-8) Gene Expression in Human Conjunctiva through the Recruitment of Both RelA and CCAAT/Enhancer-binding Protein {beta} to the IL-8 Promoter. J. Biol. Chem.
284: 4191-4199
[Abstract]
[Full Text]
-
Quement, C. L., Guenon, I., Gillon, J.-Y., Lagente, V., Boichot, E.
(2008). MMP-12 induces IL-8/CXCL8 secretion through EGFR and ERK1/2 activation in epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol.
294: L1076-L1084
[Abstract]
[Full Text]
-
Puthia, M. K., Lu, J., Tan, K. S. W.
(2008). Blastocystis ratti Contains Cysteine Proteases That Mediate Interleukin-8 Response from Human Intestinal Epithelial Cells in an NF-{kappa}B-Dependent Manner. Eukaryot Cell
7: 435-443
[Abstract]
[Full Text]
-
Venza, I., Cucinotta, M., Caristi, S., Mancuso, G., Teti, D.
(2007). Transcriptional Regulation of IL-8 by Staphylococcus aureus in Human Conjunctival Cells Involves Activation of AP-1. IOVS
48: 270-276
[Abstract]
[Full Text]
-
Boodoo, S., Spannhake, E. W., Powell, J. D., Horton, M. R.
(2006). Differential regulation of hyaluronan-induced IL-8 and IP-10 in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol.
291: L479-L486
[Abstract]
[Full Text]
-
Adam, E., Hansen, K. K., Astudillo, O. F., Coulon, L., Bex, F., Duhant, X., Jaumotte, E., Hollenberg, M. D., Jacquet, A.
(2006). The House Dust Mite Allergen Der p 1, Unlike Der p 3, Stimulates the Expression of Interleukin-8 in Human Airway Epithelial Cells via a Proteinase-activated Receptor-2-independent Mechanism. J. Biol. Chem.
281: 6910-6923
[Abstract]
[Full Text]
-
Yao, P.-L., Lin, Y.-C., Wang, C.-H., Huang, Y.-C., Liao, W.-Y., Wang, S.-S., Chen, J. J. W., Yang, P.-C.
(2005). Autocrine and Paracrine Regulation of Interleukin-8 Expression in Lung Cancer Cells. Am. J. Respir. Cell Mol. Bio.
32: 540-547
[Abstract]
[Full Text]
-
Sadikot, R. T., Blackwell, T. S., Christman, J. W., Prince, A. S.
(2005). Pathogen-Host Interactions in Pseudomonas aeruginosa Pneumonia. Am. J. Respir. Crit. Care Med.
171: 1209-1223
[Abstract]
[Full Text]
-
Linden, A., Laan, M., Anderson, G. P.
(2005). Neutrophils, interleukin-17A and lung disease. Eur Respir J
25: 159-172
[Abstract]
[Full Text]
-
Firoved, A. M., Wood, S. R., Ornatowski, W., Deretic, V., Timmins, G. S.
(2004). Microarray Analysis and Functional Characterization of the Nitrosative Stress Response in Nonmucoid and Mucoid Pseudomonas aeruginosa. J. Bacteriol.
186: 4046-4050
[Abstract]
[Full Text]
-
Epelman, S., Neely, G. G., Ma, L. L., Gjomarkaj, M., Pace, E., Melis, M., Woods, D. E., Mody, C. H.
(2002). Distinct fates of monocytes and T cells directly activated by Pseudomonas aeruginosa exoenzyme S. J. Leukoc. Biol.
71: 458-468
[Abstract]
[Full Text]
-
Leidal, K. G., Munson, K. L., Denning, G. M.
(2001). Small Molecular Weight Secretory Factors from Pseudomonas aeruginosa Have Opposite Effects on IL-8 and RANTES Expression by Human Airway Epithelial Cells. Am. J. Respir. Cell Mol. Bio.
25: 186-195
[Abstract]
[Full Text]
-
Smith, R. S., Fedyk, E. R., Springer, T. A., Mukaida, N., Iglewski, B. H., Phipps, R. P.
(2001). IL-8 Production in Human Lung Fibroblasts and Epithelial Cells Activated by the Pseudomonas Autoinducer N-3-Oxododecanoyl Homoserine Lactone Is Transcriptionally Regulated by NF-{{kappa}}B and Activator Protein-2. J. Immunol.
167: 366-374
[Abstract]
[Full Text]
-
Tsai, W. C., Strieter, R. M., Mehrad, B., Newstead, M. W., Zeng, X., Standiford, T. J.
(2000). CXC Chemokine Receptor CXCR2 Is Essential for Protective Innate Host Response in Murine Pseudomonas aeruginosa Pneumonia. Infect. Immun.
68: 4289-4296
[Abstract]
[Full Text]